Medical experts to discuss Saatchi Bill at free public event

Download PDF Copy

Nov 29 2014

NewsGuard 100/100 Score

Free public event organised by the University of Leicester School of Law
Synopsis:

The Saatchi Bill claims that it will help doctors to innovate new treatments and cures, safely and responsibly, for cancer and other diseases. This event brings together the experts from law and medicine to discuss how this aim might be achieved and whether the Saatchi Bill will facilitate innovation without jeopardising patient safety.

To be given by Professor José Miola of the School of Law and Professor Dean Fennell of the Department of Cancer Studies.

Source: University of Leiceste

Posted in: Healthcare News

Tags: Apoptosis, Cancer, Lung Cancer, Medical Litigation, Medicine, Mesothelioma, Oncology

Comments (0)

Download PDF Copy

Suggested Reading

Revolutionary strategy offers hope for type 1 diabetes treatment

Revolutionary strategy offers hope for type 1 diabetes treatment

Study shows AI can predict prognosis in triple-negative breast cancer

Study shows AI can predict prognosis in triple-negative breast cancer

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Adding high-dose IV vitamin C to chemotherapy can boost survival for pancreatic cancer patients

Researchers uncover key genes linked to DCIS progression

Researchers uncover key genes linked to DCIS progression

How different types of bread impact cancer risk

How different types of bread impact cancer risk

AI models redefine TIL scoring in breast cancer but face challenges in real-world validation

AI models redefine TIL scoring in breast cancer but face challenges in real-world validation

Golgi apparatus plays crucial role in enhancing T-cell function against cancer

Golgi apparatus plays crucial role in enhancing T-cell function against cancer

Nanomedicine using gas bubbles offers hope for lung cancer treatment

Nanomedicine using gas bubbles offers hope for lung cancer treatment

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients